Evidence map›Paper›PMID 31010222›Full record

ArticleMarine drugs2019

C-phycocyanin from

Ye-Ri Kim, Jeong-Mi Do, Kyung Hee Kim, Alexandra R Stoica, Seung-Woo Jo, Un-Kyung Kim, Ho-Sung Yoon

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ye-Ri KimDepartment of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Korea. yell_90@knu.ac.kr.
Jeong-Mi DoDepartment of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Korea. leciel631@naver.com.
Kyung Hee KimDepartment of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Korea. kkh5566@knu.ac.kr.
Alexandra R StoicaDepartment of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Korea. alexa_stoica93@yahoo.ro.
Seung-Woo JoDepartment of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Korea. jsw8796@gmail.com.
Un-Kyung KimDepartment of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Korea. kimuk@knu.ac.kr.
Ho-Sung YoonDepartment of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Korea. hsy@knu.ac.kr.
Kyungpook National University · KR

Funding

National Research Foundation of Korea 2017R1A2B400216
6 · The paper itself

Abstract

Ototoxicity, or adverse pharmacological effects on the inner ear or auditory nerve, is a common side effect of cisplatin, a platinum-based drug widely used in anticancer chemotherapy. Although the incidence of ototoxicity is high among patients that receive cisplatin therapy, there is currently no effective treatment for it. The generation of excessive reactive oxygen species (ROS) is considered to be the major cause of cisplatin-induced ototoxicity. C-phycocyanin (C-PC), a blue phycobiliprotein found in cyanobacteria and red algae, has antioxidant and anticancer activities in different experimental models in vitro and in vivo. Thus, we tested the ability of C-PC from

Indexed as

AnimalsAntineoplastic AgentsApoptosisbcl-2-Associated X ProteinCaspase 3Cell Cycle CheckpointsCell LineCell SurvivalCisplatinCyanobacteriaHair Cells, AuditoryHearing LossMiceMitochondriaPhycocyaninProtective AgentsAntineoplastic AgentsBax protein, mousebcl-2-Associated X ProteinBcl2 protein, mouseCaspase 3CisplatinPhycocyaninProtective AgentsProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciescisplatinC-phycocyaninHEI-OC1Limnothrixototoxicity

Identifiers

PMID31010222
PMCPMC6521143
OpenAlexW2941375619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.